Jun 10, 2021 Dr. Seth Lederman joins the Becker’s Panel to discuss the future of value in biopharma - The Becker’s Panel - June 10, 2021
Mar 29, 2021 Dr. Seth Lederman interviewed by Christine Corrado of Proactive to discuss the preliminary results of its COVID-19 vaccine candidate
Mar 29, 2021 Dr. Seth Lederman spoke to Proactive on the group's 2020 financial results and update on its second Phase 3 study of fibromyalgia.
Jan 11, 2021 Dr. Seth Lederman interviewed by Christine Corrado of Proactive to discuss Tonix’s second collaboration with Massachusetts General Hospital
Jan 6, 2021 Dr. Seth Lederman interviewed on ABC FOX Montana to discuss highlights of Tonix’s planned vaccine manufacturing facility in Hamilton, MT
Dec 15, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the positive Phase 3 results from its fibromyalgia trial using TNX-102 SL
Dec 4, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss the similarities between a circa 1860 U.S. smallpox vaccine and horsepox virus
Dec 4, 2020 Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development.
Aug 11, 2020 Dr. Seth Lederman presents a vaccine tutorial covering the challenges and opportunities of developing a vaccine for COVID-19
Jul 17, 2020 Dr. Seth Lederman interviewed by Christine Corrado of Proactive Investors to discuss strategic partnerships in developing vaccines for COVID-19
Jul 8, 2020 Dr. Seth Lederman interviewed by Jane King on New to the Street to discuss Tonix’s portfolio of product candidates to fight COVID-19
Jul 8, 2020 Dr. Seth Lederman interviewed on Bloomberg TV to discuss the goals & timeline for development of TNX-1800, Tonix’s live replicating COVID-19 vaccine candidate.
Jun 17, 2020 Seth Lederman interviewed by KWTX’s Haley Vyrostek about Tonix’s partnership with Fujifilm Diosynth to manufacture and develop their COVID-19 vaccine candidate, TNX-1800, for clinical trial supply.
